journal article·2025-11Open access

Quantitative Profiling of Nanoscopic Protein Aggregates Reveals Specific Fingerprint of TDP‐43‐Positive Assemblies in Motor Neuron Disease

Dezerae Cox, Melanie Burke, Sara Milani, Matthew A White, Fergal M Waldron, Dorothea Böken, Evgeniia Lobanova, Jemeen Sreedharan, Jenna M Gregory, David Klenerman

Advanced Science· Volume 12· Issue 44

Abstract

Abstract Abnormal aggregation of TAR DNA‐binding protein 43 (TDP‐43) is a pathological hallmark of motor neuron disease (MND), yet current methods for quantifying these aggregates in biological samples remain limited in sensitivity and resolution. Here, single‐molecule fluorescence microscopy is applied to post‐mortem brain extracts to quantitatively characterize aggregates containing TDP‐43 at the individual particle level. The resulting aggregate fingerprints, consisting of morphological and compositional profiles, are sufficient to distinguish MND donors from neurologically normal controls and further discriminate between clinically distinct MND subgroups. Comparative proteomic analysis confirms and extends these findings, revealing convergent and complementary molecular signatures. These results demonstrate, for the first time, that single‐molecule aggregate profiling can stratify MND cases using patient‐derived tissues, paving the way for the development of sensitive minimally invasive diagnostics and mechanistically informed disease monitoring tools.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Amyotrophic Lateral Sclerosis Research · Prion Diseases and Protein Misfolding · Neurogenetic and Muscular Disorders Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Yusuf Hamied Department of Chemistry University of Cambridge Cambridge CB2 1EW UK

UK Dementia Research Institute Cambridge CB2 0XY UK

Molecular Horizons and School of Science University of Wollongong Wollongong 2500 Australia

Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience King's College London London SE5 9RT UK

Institute of Medical Sciences University of Aberdeen Foresterhill Aberdeen AB25 2ZD UK

Funding

Target ALS · Parkinson's UK · Rosetrees Trust

References (52)

Show source-provided references
1. 10.1002/ana.2114710.1002/ana.21147 ↗
2. 10.1186/s13024-020-00397-110.1186/s13024-020-00397-1 ↗
3. 10.1074/jbc.M109.01026410.1074/jbc.M109.010264 ↗
4. 10.3390/ijms2208384310.3390/ijms22083843 ↗
5. 10.1093/brain/awad14510.1093/brain/awad145 ↗
6. 10.1038/srep1341610.1038/srep13416 ↗
7. 10.1038/s41598-017-14399-510.1038/s41598-017-14399-5 ↗
8. 10.1074/jbc.M111.28872010.1074/jbc.M111.288720 ↗
9. 10.1038/s41467-020-14815-x10.1038/s41467-020-14815-x ↗
10. 10.1038/ncomms582410.1038/ncomms5824 ↗
11. 10.1038/s41586-021-04199-310.1038/s41586-021-04199-3 ↗
12. 10.1002/anie.20231775610.1002/anie.202317756 ↗
13. 10.1038/s41467-022-33252-610.1038/s41467-022-33252-6 ↗
14. 10.1186/s40478-019-0777-410.1186/s40478-019-0777-4 ↗
15. 10.1038/nature1001610.1038/nature10016 ↗
16. 10.1016/j.bbrc.2011.11.06610.1016/j.bbrc.2011.11.066 ↗
17. 10.1093/hmg/ddp27510.1093/hmg/ddp275 ↗
18. 10.3389/fnmol.2018.0037210.3389/fnmol.2018.00372 ↗
19. 10.1074/jbc.M116.73925010.1074/jbc.M116.739250 ↗
20. 10.1007/978-1-4939-2080-8_1410.1007/978-1-4939-2080-8_14 ↗
21. 10.1016/j.neuron.2013.07.03310.1016/j.neuron.2013.07.033 ↗
22. 10.1038/s41557-022-00976-310.1038/s41557-022-00976-3 ↗
23. 10.1016/j.ijpharm.2019.01.01510.1016/j.ijpharm.2019.01.015 ↗
24. 10.1007/s00401-008-0477-910.1007/s00401-008-0477-9 ↗
25. 10.1186/s40478-016-0301-z10.1186/s40478-016-0301-z ↗
26. 10.1038/s41467-022-29661-210.1038/s41467-022-29661-2 ↗
27. 10.1093/brain/aww23710.1093/brain/aww237 ↗
28. 10.1038/s41467-017-02017-x10.1038/s41467-017-02017-x ↗
29. 10.1016/j.isci.2023.10664510.1016/j.isci.2023.106645 ↗
30. 10.1007/s00401-013-1125-610.1007/s00401-013-1125-6 ↗
31. 10.1371/journal.pone.003865810.1371/journal.pone.0038658 ↗
32. 10.1038/s41593-023-01341-410.1038/s41593-023-01341-4 ↗
33. 10.3390/jpm1210174710.3390/jpm12101747 ↗
34. 10.1016/j.jns.2024.12321010.1016/j.jns.2024.123210 ↗
35. 10.1038/nrn388710.1038/nrn3887 ↗
36. 10.1038/s12276-020-00513-710.1038/s12276-020-00513-7 ↗
37. 10.4103/1673-5374.33613910.4103/1673-5374.336139 ↗
38. 10.1186/s40478-022-01408-610.1186/s40478-022-01408-6 ↗
39. 10.1016/j.isci.2023.10664510.1016/j.isci.2023.106645 ↗
40. 10.1038/s41467-024-53547-010.1038/s41467-024-53547-0 ↗
41. 10.1007/s00401-018-1846-710.1007/s00401-018-1846-7 ↗
42. 10.1016/0896-6273(92)90117-V10.1016/0896-6273(92)90117-V ↗
43. 10.1021/acsami.4c0651210.1021/acsami.4c06512 ↗
44. 10.7717/peerj.45310.7717/peerj.453 ↗
45. 10.1038/s41592-019-0686-210.1038/s41592-019-0686-2 ↗
46. 10.1038/nprot.2017.02410.1038/nprot.2017.024 ↗
47. Pedregosa F. · J. Mach. Learn. Res. · 2011 · 12 · 2825
48. 10.7717/peerj.431210.7717/peerj.4312 ↗
49. 10.25080/Majora-92bf1922-00a10.25080/Majora-92bf1922-00a ↗
50. 10.1038/s41540-022-00256-310.1038/s41540-022-00256-3 ↗
51. F. M.Waldron J.Gregory Protocols.io2024 https://dx.doi.org/10.17504/protocols.io.yxmvm97k6l3p/v110.17504/protocols.io.yxmvm97k6l3p/v1 ↗
52. 10.1007/s00401-024-02705-110.1007/s00401-024-02705-1 ↗